Regulations.gov document
Exhibit B - "Draft Guidance on Venalfaxine Hydrochloride" - [Sun Pharmaceutical…
Supporting & Related Material · FDA-2010-P-0255 · posted Jul 30, 2010
Key facts
| Document ID | FDA-2010-P-0255-0005 |
|---|---|
| Title | Exhibit B - "Draft Guidance on Venalfaxine Hydrochloride" - [Sun Pharmaceutical Industries, Ltd., (Winston & Strawn LLP) - Comment] re FDA-2010-P-0255-0003 |
| Document type | Supporting & Related Material |
| Subtype | C-Comment (Supporting and Related Material) |
| Agency | FDA |
| Docket | FDA-2010-P-0255 |
| Posted | Jul 30, 2010 |
| Effective date | Jul 15, 2010 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: